Category: Latest News
-

Quantum Computing Inc. Signs Three-Year Agreement With Hamad Bin Khalifa University
Quantum Computing Inc. (NASDAQ:QUBT) has entered into a three-year framework agreement with Hamad Bin Khalifa University in Qatar covering collaboration in quantum computing, quantum sensing and quantum communications. The agreement includes joint academic research, executive education programmes, industry-focused projects, application development and co-marketing activities. Financial terms were not disclosed. QCi to Provide Access to Dirac-3…
-

Mobilicom Receives Follow-On Ground Control Station Order From Asian Customer
Mobilicom Limited (NASDAQ:MOB) said it received a follow-on production order for its Mobile Ground Control Stations from an Asia-based conglomerate that manufactures robotics platforms for military and industrial applications. The value and other financial terms of the order were not disclosed. Customer Has Ordered Across Three Mobilicom Product Families According to Mobilicom, the unnamed customer…
-

Nasdaq Leads US Stocks Lower as AI Development Debate Weighs on Technology Sector: Dow Jones, S&P, Wall Street
US stocks opened lower on Monday, led by declines in technology shares after several artificial intelligence industry executives called for a slowdown in the development of advanced AI models. At 09:32 ET (13:32 GMT), the S&P 500 was down 0.7% at 7,603.80 points, while the NASDAQ Composite fell 1.6% to 28,902.20. The Dow Jones Industrial…
-

Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation
Armata Pharmaceuticals (AMEX:ARMP) shares rose 8% after the company said the US Food and Drug Administration granted Breakthrough Therapy designation to AP-SA02, its intravenously administered Staphylococcus aureus multi-phage product candidate. The designation covers AP-SA02 as an adjunct treatment for complicated bacteremia caused by methicillin-sensitive S. aureus, or MSSA, and methicillin-resistant S. aureus, or MRSA. FDA…
-

Corteva Board Approves Seed Business Spinoff as Vylor
Corteva (NYSE:CTVA) said its board has approved the separation of the company’s seed operating segment into an independent, publicly traded company named Vylor Inc. Vylor is expected to list on the New York Stock Exchange under the ticker symbol VYLR following completion of the separation. Corteva shareholders of record at the close of business on…
-

Johnson & Johnson Shares Rise on Reported Apollo Talks for Orthopedics Unit
Johnson & Johnson (NYSE:JNJ) shares rose 1.3% to $268.96 in pre-market trading on Monday following a report that Apollo Global Management (NYSE:APO) is in discussions to acquire the healthcare group’s orthopedics business. Bloomberg News reported on Friday that a potential transaction could value the division at close to $20 billion, citing people familiar with the…
-

Definium Therapeutics Shares Rise 20% After Phase 3 Anxiety Trial Meets Primary Endpoint
Definium Therapeutics, Inc. (NASDAQ:DFTX) shares rose 20% after the company reported topline results from its Phase 3 Panorama study evaluating DT120 ODT in patients with generalized anxiety disorder. The study met its primary endpoint and all key secondary efficacy endpoints. Participants receiving DT120 ODT 100 µg showed a statistically significant reduction in Hamilton Anxiety Rating…
-

Largo Restructures Debt and Begins Copper-PGM Concentrate Sales
Largo Inc. (NASDAQ:LGO) announced a series of financing, operational and commercial updates, including a debt-restructuring agreement with Caixa Econômica Federal and its first sales of copper-platinum group metals concentrate. The company also said its 2026 vanadium production is now expected to be at the lower end of its previously announced guidance range as it temporarily…
-

Corbus Pharmaceuticals Shares Rise 12% After CANYON-1 Obesity Trial Data
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) shares rose 12% on Monday after the company reported topline results from its CANYON-1 Phase 1b clinical trial evaluating CRB-913 as a treatment for obesity. The study showed statistically significant mean weight loss compared with placebo across all three doses tested, with the highest 60 mg dose producing mean weight…
-

Stellantis Shares Fall After Morgan Stanley Downgrades Stock to Underweight
Stellantis (NYSE:STLA) shares fell more than 2% on Monday after Morgan Stanley downgraded the automaker to Underweight from Equal Weight and reduced its price target to $5.20 from $8.00. The rating change formed part of a broader review of European automakers by analysts led by Javier Martinez de Olcoz Cerdan. The analysts cited changes in…